Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 7Genitourinary 4CNS 3Breast 3Gynecologic 2Other 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Pituitary Neoplasms 1

Interventions

lanreotide 5Octreotide 5Everolimus 4Dexmedetomidine 3Cabergoline 3pasireotide 2Phenoxybenzamine 2Carboplatin 2trametinib 1testosterone enanthate 1surufatinib 1selpercatinib 1pralsetinib 1pegvisomant 1lutetium Lu 177 dotatate 1lenvatinib 1larotrectinib 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1entrectinib 1dabrafenib 1candesartan 1arginyllysine 1anlotinib 1Vitamin D 1Trimethoprim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Propofol × Endocrine × Clear all
NCT05822817 2025-06-08

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

Peking Union Medical College Hospital

Phase 4 Completed
252 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡